Trisalus Life Sciences, Inc. · NASDAQ:TLSI
Szela Mary T received 8,478 Trisalus Life Sciences, Inc. shares as an award (Form 5)
Traded Dec 31, 2024 to Dec 31, 2025 · Filed Jul 1, 2026
From Dec 31, 2024 to Dec 31, 2025, Szela Mary T (Director, CEO and President) received 8,478 Trisalus Life Sciences, Inc. shares as an award at an average US$4.28 for US$36,283, leaving 1,023,826 shares. Filed Jul 1, 2026 (Form 5).
- Awarded
- 8,478 shares
- Price
- US$4.28 average (US$4.23 to US$4.38)
- Value
- US$36,283
- Holding after
- 1,023,826 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Dec 31, 2024 | Common Stock | Award | 3,530 | US$4.26 | 513,207 | Direct |
| Jun 30, 2025 | Common Stock | Award | 2,848 | US$4.23 | 596,726 | Direct |
| Dec 31, 2025 | Common Stock | Award | 2,100 | US$4.38 | 1,023,826 | Direct |
Source
Related
- Trisalus Life Sciences, Inc.
- Szela Mary T
- Trisalus Life Sciences, Inc. shareholders
- Form 4 · Szela Mary T · Oct 7, 2026
- Form 4 · Szela Mary T · Jul 1, 2026
- Form 4 · Szela Mary T · May 18, 2026
- Form 4 · Cox Bryan F. · Oct 7, 2026
- Form 4 · Marshak Richard · Oct 7, 2026
- Form 4 · Stevens Jennifer · Oct 7, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Jul 7, 2026
- Form 4 · Patience David · Jul 6, 2026